Vacha (Calamus) for Respiratory Health

Research suggests that Acorus calamus (Vacha) may offer meaningful support for respiratory health through several identified mechanisms, with animal studies demonstrating that its extracts and active compounds — particularly alpha-asarone — can reduce airway inflammation, suppress mast cell activity, inhibit allergic responses, and produce bronchodilatory effects via anticholinergic and calcium channel pathways. Studies indicate these effects involve multiple signaling pathways including ERK/JAK2-STAT3 and PI3K-Akt, with additional laboratory work suggesting potential activity against respiratory syncytial virus. The body of evidence is largely preclinical, consisting primarily of animal models, network pharmacology analyses, and traditional use reviews, with one small homeopathic clinical study and no rigorous human clinical trials specifically targeting respiratory outcomes, which represents a significant gap in the literature. Importantly, a mixed finding from one study noted that beta-asarone may inhibit respiratory neurotransmission at higher doses, and safety reviews have flagged genotoxic and mutagenic potential for asarone compounds, meaning the overall picture — while promising in early research — requires considerably more clinical investigation before firm conclusions can be drawn.